Access brought to you by: LOCKSS

Hypertensive Disease

24-Hour ceABP is a Better Measurement in Young Patients
SYMPLICITY HTN-3 Trial: No Blood Pressure Reduction in Patients with Resistant Hypertension Treated with Renal Denervation
Blood Pressure Variability after ICH Predicts Poor Outcomes
No Benefit to Renal Artery Stenting Seen in CORAL Trial
Immediate Targeted Blood Pressure Reduction Does Not Improve Outcomes in Acute Stroke
Renal Denervation and Renal Stenting are Beginning to Show Benefits in Hypertension and Other Conditions
Hypercholesteremia, Hypertension, and Antiplatelet Therapy in PAD
Management of Cardiovascular Risk Factors in Asymptomatic Patients with Hypertension
Left Ventricular Remodeling Reduced with Olmesartan in ROADMAP
Even Small Improvements in Control of Hypertension May Improve Cardiac Function in Afro-Caribbean Individuals

Pages